ATE44235T1 - Verwendung von kupfer und fettsaeulen. - Google Patents
Verwendung von kupfer und fettsaeulen.Info
- Publication number
- ATE44235T1 ATE44235T1 AT85306551T AT85306551T ATE44235T1 AT E44235 T1 ATE44235 T1 AT E44235T1 AT 85306551 T AT85306551 T AT 85306551T AT 85306551 T AT85306551 T AT 85306551T AT E44235 T1 ATE44235 T1 AT E44235T1
- Authority
- AT
- Austria
- Prior art keywords
- copper
- gamma
- linolenic acid
- acids
- calculated
- Prior art date
Links
- 239000005749 Copper compound Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 2
- 150000001880 copper compounds Chemical class 0.000 abstract 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 2
- 229960002733 gamolenic acid Drugs 0.000 abstract 2
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848425006A GB8425006D0 (en) | 1984-10-03 | 1984-10-03 | Composition of copper/fatty acids |
| EP85306551A EP0181689B1 (de) | 1984-10-03 | 1985-09-16 | Verwendung von Kupfer und Fettsäulen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE44235T1 true ATE44235T1 (de) | 1989-07-15 |
Family
ID=10567647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85306551T ATE44235T1 (de) | 1984-10-03 | 1985-09-16 | Verwendung von kupfer und fettsaeulen. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4965075A (de) |
| EP (1) | EP0181689B1 (de) |
| JP (1) | JPS61171419A (de) |
| AT (1) | ATE44235T1 (de) |
| AU (1) | AU581252B2 (de) |
| CA (1) | CA1268116A (de) |
| DE (1) | DE3571200D1 (de) |
| GB (1) | GB8425006D0 (de) |
| IE (1) | IE58492B1 (de) |
| ZA (1) | ZA857182B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8516906D0 (en) * | 1985-07-04 | 1985-08-07 | Efamol Ltd | Pharmaceutical & dietary composition |
| GB8524276D0 (en) * | 1985-10-02 | 1985-11-06 | Efamol Ltd | Pharmaceutical & dietary compositions |
| GB8621816D0 (en) * | 1986-09-10 | 1986-10-15 | Efamol Ltd | Therapeutic composition |
| US4851431A (en) * | 1986-11-26 | 1989-07-25 | Bar Ilan University | Physiologically active and nutritional composition |
| US5599840A (en) * | 1986-11-26 | 1997-02-04 | Bar Ilan University | Physiologically active and nutritional composition |
| GB8715914D0 (en) * | 1987-07-07 | 1987-08-12 | Efamol Ltd | Treatment of cerabral disorders |
| US5034415A (en) * | 1987-08-07 | 1991-07-23 | Century Laboratories, Inc. | Treatment of diabetes mellitus |
| JP2716739B2 (ja) * | 1988-07-26 | 1998-02-18 | インデナ エス．ピー．エイ | 血管運動作用を有する化粧用組成物 |
| IL91802A (en) * | 1988-10-27 | 1994-05-30 | Univ Bar Ilan | Preparations containing linoleic acid history for the treatment of Alzheimer's, similar brain diseases, and epilepsy |
| US5411748A (en) * | 1992-10-22 | 1995-05-02 | Song Moon K | Prostate extract supplemented with zinc |
| CA2151820C (en) * | 1993-01-15 | 2000-11-28 | Stephen Joseph Demichele | Structured lipids |
| DK0661049T3 (da) * | 1993-12-31 | 2000-02-14 | Univ Limburg | Anvendelse af essentielle fedtsyresammensætninger |
| US6107334A (en) * | 1998-02-23 | 2000-08-22 | Wake Forest University | Dietary control of arachidonic acid metabolism |
| US7138431B1 (en) * | 1998-02-23 | 2006-11-21 | Wake Forest University | Dietary control of arachidonic acid metabolism |
| US6548540B2 (en) * | 1998-09-08 | 2003-04-15 | Charlotte-Mecklenburg Hospital Authority | Method of treating cancer using dithiocarbamate derivatives |
| CA2436650A1 (en) * | 2003-08-06 | 2005-02-06 | Naturia Inc. | Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses |
| US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
| US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
| CN107072959A (zh) | 2014-06-04 | 2017-08-18 | 尊严科学有限公司 | 包含二高γ亚麻酸(DGLA)的医药组合物以及其用途 |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1082624A (en) * | 1965-02-26 | 1967-09-06 | Calmic Ltd | Improvements in or relating to therapeutically active compounds |
| GB1240513A (en) * | 1968-09-13 | 1971-07-28 | Ono Pharmaceutical Co | Poly-unsaturated fatty acid ester composition and its preparation |
| US4237118A (en) * | 1972-03-06 | 1980-12-02 | Howard Alan N | Dietary supplement and dietary methods employing said supplement for the treatment of obesity |
| GB1446431A (en) * | 1972-04-20 | 1976-08-18 | Williams J | Nutritional supplement |
| US3953591A (en) * | 1974-04-29 | 1976-04-27 | The Procter & Gamble Company | Fatty acid, polysiloxane and water-soluble polymer containing skin conditioning emulsion |
| CH621048A5 (de) * | 1977-04-27 | 1981-01-15 | Nestle Sa | |
| JPS5490121A (en) * | 1977-11-28 | 1979-07-17 | Boettcher Barry | Neutral copper bonded body and antiinflaming agent |
| IE47777B1 (en) * | 1978-01-23 | 1984-06-13 | Efamol Ltd | Pharmaceutical and dietary composition comprising gamma-linolenic acids |
| AU520987B2 (en) * | 1978-05-08 | 1982-03-11 | Victor Alexander Garten | Anti-arthritic preparation |
| FR2514643B1 (fr) * | 1981-10-20 | 1986-07-04 | Oreal | Lanolate de cuivre et compositions cosmetiques anti-acneiques le contenant |
| EP0092076B1 (de) * | 1982-04-16 | 1986-12-17 | Societe Des Produits Nestle S.A. | Lipidhaltige Zusammensetzung für die orale, enterale oder parenterale Ernährung |
| CA1225597A (en) * | 1982-09-22 | 1987-08-18 | Jakobus Booyens | Prophylactic substance or composition |
| GB8317248D0 (en) * | 1983-06-24 | 1983-07-27 | Wyeth John & Brother Ltd | Fat compositions |
-
1984
- 1984-10-03 GB GB848425006A patent/GB8425006D0/en active Pending
-
1985
- 1985-09-16 AT AT85306551T patent/ATE44235T1/de not_active IP Right Cessation
- 1985-09-16 EP EP85306551A patent/EP0181689B1/de not_active Expired
- 1985-09-16 DE DE8585306551T patent/DE3571200D1/de not_active Expired
- 1985-09-19 ZA ZA857182A patent/ZA857182B/xx unknown
- 1985-09-19 IE IE231785A patent/IE58492B1/en not_active IP Right Cessation
- 1985-09-30 AU AU47998/85A patent/AU581252B2/en not_active Ceased
- 1985-10-02 JP JP60218175A patent/JPS61171419A/ja active Pending
- 1985-10-02 CA CA000492096A patent/CA1268116A/en not_active Expired - Fee Related
-
1988
- 1988-11-21 US US07/273,680 patent/US4965075A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0181689B1 (de) | 1989-06-28 |
| AU581252B2 (en) | 1989-02-16 |
| IE58492B1 (en) | 1993-09-22 |
| GB8425006D0 (en) | 1984-11-07 |
| ZA857182B (en) | 1986-05-28 |
| CA1268116A (en) | 1990-04-24 |
| JPS61171419A (ja) | 1986-08-02 |
| US4965075A (en) | 1990-10-23 |
| AU4799885A (en) | 1986-04-10 |
| EP0181689A1 (de) | 1986-05-21 |
| DE3571200D1 (en) | 1989-08-03 |
| IE852317L (en) | 1986-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE44235T1 (de) | Verwendung von kupfer und fettsaeulen. | |
| AU586892B2 (en) | Pharmaceutical and dietary composition | |
| AU562938B2 (en) | 7, 10, 13, 16 docosatetraenoic acid composition | |
| GR3006068T3 (de) | ||
| FR2564863B1 (fr) | Procede d'elaboration d'un alliage ferreux a haute teneur en manganese par fusion reductrice. | |
| EP0150709A3 (de) | 7-Oxabicycloheptan-Prostaglandin-Analoge | |
| IE830265L (en) | Pharmaceutical composition | |
| AU7018187A (en) | Iron - containing composition and method for treatment of cancer | |
| DE3485337D1 (de) | Topische zubereitungen mit gehalt an teer und fettsaeuren. | |
| EP0201159A3 (en) | Pharmaceutical and dietary compositions containing linolenic acids for the treatment of benign prostatic hypertrophy | |
| AU4629885A (en) | 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives | |
| HUT45035A (en) | Process for producing thiazolone derivatives | |
| AU570552B2 (en) | 1,4-dihydropyridine-3-carboxylates and salts thereof | |
| AU1145583A (en) | Composition containing an essential fatty acid and brotin | |
| SE8800988D0 (sv) | Pharmaceutical compositons acting on the heart and cardiovascular system and process for preparing same | |
| NO891679D0 (no) | Fremgangsmaate for fremstilling av 5-klor-3-klorsulfonyl-2-tiofenkarbonsyreestere. | |
| IL89142A0 (en) | Method for the sequential oxidation of substituted-8-hydroxyquinolines to produce substituted-pyridine-2,3-dicarboxylic acids | |
| KR960015807B1 (en) | Process for the preparation of purified bis(2-hydrozyethyl) ester of 2,60naphthalenedi carboxylic acid | |
| IE792328L (en) | Derivatives of dihydropyrrole and tetrahydropyridine. | |
| DE2964718D1 (en) | Process for the preparation of 7-oxabicyclo(4.1.0)heptane-3,4-dicarboxylic acid diglycidyl ester | |
| PT83192B (en) | Process for preparing unsaturated compounds useful in the treatment of cardiovascular phatological conditions containing 1,4-di-hydropiridine-3,5-dicarboxylic acid derivatives | |
| DE2964538D1 (en) | Process for the preparation of 7-oxabicyclo(4.1.0)heptane-3,4-dicarboxylic acid diglycidyl ester | |
| BG52067B2 (en) | Antihypoxic and brain-protection antidote composition | |
| ATE46338T1 (de) | Verfahren zur herstellung von 3-cephem-4 carboxylsaeure-derivaten, substituiert in position 3. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |